NCT06339151

Brief Summary

The goal of this clinical trial is to investigate the efficacy of single dose and double dose of dexamethasone after primary total knee replacement. The main question\[s\] it aims to answer \[is/are\]: Does 24 hours-interval of double dose of dexamethasone have better analgesic effect than single dose and 12 hours interval of double dose of dexamethasone after primary total joint replacement? Researchers will compare double dose of dexamethasone group to see if \[insert effects\]. Participants will \[describe the main tasks participants will be asked to do, interventions they'll be given and use bullets if it is more than 2 items\].

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 23, 2022

Completed
2 years until next milestone

First Submitted

Initial submission to the registry

March 24, 2024

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 1, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2025

Completed
Last Updated

April 9, 2025

Status Verified

April 1, 2024

Enrollment Period

3.6 years

First QC Date

March 24, 2024

Last Update Submit

April 5, 2025

Conditions

Keywords

total knee arthroplastydexamethasone

Outcome Measures

Primary Outcomes (1)

  • Pain at rest and motion

    Using visual analog scale 0-10 (0 means best, 10 means worst)

    At 6 hour, 12 hour, 18 hour, 24 hour, 30 hour, 36 hour, 42 hour, 48 hour, 54 hour, 60 hour, 66 hour and 72 hour after surgery

Secondary Outcomes (7)

  • Nausea and vomiting

    At 24 hour, 48 hour and 72 hour after surgery

  • Morphine consumption

    At 24 hour, 48 hour and 72 hour after surgery

  • Blood sugar level

    At 24 hour and 48 hour after surgery

  • CRP level

    At 24 hour and 48 hour after surgery

  • Range of motion

    At 24 hour and 48 hour after surgery

  • +2 more secondary outcomes

Study Arms (3)

Group 1

ACTIVE COMPARATOR

Preoperative - Dexamethasone 0.15 mg/kg injection by the anesthesiologist 30 minutes before surgery. Postoperative 12 hr - Normal saline solution injection Postoperative 24 hr - Normal saline solution injection

Drug: Dexamethasone before surgery

Group 2

ACTIVE COMPARATOR

Preoperative - Dexamethasone 0.15 mg/kg injection by the anesthesiologist 30 minutes before surgery. Postoperative 12 hr - Dexamethasone 0.15 mg/kg IV at 12 hours post operation Postoperative 24 hr - Normal saline solution injection

Drug: Dexamethasone before and 12 hours after surgery

Group 3

ACTIVE COMPARATOR

Preoperative - Dexamethasone 0.15 mg/kg injection by the anesthesiologist 30 minutes before surgery. Postoperative 12 hr - Normal saline solution injection Postoperative 24 hr - Dexamethasone 0.15 mg/kg IV at 24 hours post operation

Drug: Dexamethasone before and 24 hours after surgery

Interventions

Dexamethasone 0.15 mg/kg IV before surgery

Group 1

Dexamethasone 0.15 mg/kg IV before surgery Dexamethasone 0.15 mg/kg IV at 12 hours post operation

Group 2

Dexamethasone 0.15 mg/kg IV before surgery Dexamethasone 0.15 mg/kg IV at 24 hours post operation

Group 3

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of primary osteoarthritis of knee joint
  • Undergo unilateral primary total knee replacement
  • Age between 50-85 years old

You may not qualify if:

  • Allergy to dexamethasone
  • History of long term corticosteroid used
  • New York heart association (NYHA) class \> II
  • Type 2 Diabetes mellitus that had HbA1c \> 7 % or FBS \> 200 mg/dl
  • Chronic kidney disease \> stage III or eGFR \< 60
  • Cirrhosis Child class B or C
  • Cannot use pain controlled as protocol
  • History of previous knee surgery
  • History of previous septic arthritis at knee joint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Thammasat University Hospital

Khlong Luang, Changwat Pathum Thani, 12120, Thailand

Location

Related Publications (1)

  • Xu H, Zhang S, Xie J, Lei Y, Cao G, Pei F. Multiple Doses of Perioperative Dexamethasone Further Improve Clinical Outcomes After Total Knee Arthroplasty: A Prospective, Randomized, Controlled Study. J Arthroplasty. 2018 Nov;33(11):3448-3454. doi: 10.1016/j.arth.2018.06.031. Epub 2018 Jul 4.

    PMID: 30033064BACKGROUND

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Postoperative Period

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Perioperative PeriodSurgical Procedures, OperativePatient CareHealth ServicesHealth Care Facilities Workforce and Services

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dr.

Study Record Dates

First Submitted

March 24, 2024

First Posted

April 1, 2024

Study Start

March 23, 2022

Primary Completion

October 31, 2025

Study Completion

October 31, 2025

Last Updated

April 9, 2025

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations